Immatics combines the discovery of true targets for cancer immunotherapies with the development of the right T cell receptors with the goal of enabling a robust and specific T cell response against these targets. 

Pharmaceutical

Immatics

Immatics' headquarters in Tübingen, Germany

Harpreet Singh

Cedrik Britten

Rainer Kramer

Steffen Walter

Carsten Reinhardt

Toni Weinschenk

Amie Krause

Venkat Ramanan

Michael Mølhøj

Edward Sturchio

Roland Kontermann

Gwendolyn Binder

Hidde Ploegh

Heather L. Mason

Michael G. Atieh

Adam Stone

Crystal Mackall

Anne Kerber

Peter Chambré

Hans-Georg Rammensee

Patrick Hwu

Cassian Yee

This department focuses on advancing scientific knowledge and developing new products or technologies through rigorous experimentation and analysis.

Research and Development

This department oversees the planning, execution, and management of clinical trials and research activities to ensure compliance and quality in clinical research.

Clinical Operations

The Vice Presidents at Immatics are key leaders responsible for overseeing various strategic and operational functions critical to advancing the company's mission in cancer immunotherapy. They lead departments in target and T cell receptor research, clinical development, regulatory affairs, quality operations, business development, and more, ensuring alignment with corporate goals and the successful development and commercialization of innovative cancer treatment solutions.

Vice Presidents

This department conducts and manages research projects, analyzes data, and develops findings to support organizational goals.

Research Department

The Leadership Team at Immatics is responsible for guiding the company’s strategic vision and operational execution in the development of innovative cancer immunotherapies. Comprising executives from finance, regulatory affairs, business development, and medical fields, the team collaborates to align research, development, and commercialization efforts, ensuring the effective delivery of robust T cell therapies to patients. Through their combined expertise, they drive initiatives that enhance target discovery and T cell receptor development, facilitating breakthroughs in cancer treatment.

Leadership Team

Leadership Tübingen

Immatics

Org chart

Board & advisors

Teams

Research and Development

Clinical Operations

Vice Presidents

Research Department

Leadership Team

Leadership Tübingen

Offices

Immatics

Org chart

Board & advisors

Teams

Research and Development

Clinical Operations

Vice Presidents

Research Department

Leadership Team

Leadership Tübingen

Offices

Related companies